ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.4500
-0.0139 (-3.00%)
At close: Apr 25, 2025, 4:00 PM
0.4484
-0.0016 (-0.36%)
Pre-market: Apr 28, 2025, 8:26 AM EDT

ImmunoPrecise Antibodies Market Cap

ImmunoPrecise Antibodies has a market cap or net worth of $20.59 million as of April 28, 2025. Its market cap has decreased by -43.73% in one year.

Market Cap
20.59M
Enterprise Value
20.60M
1-Year Change
-43.73%
Ranking
Category
Stock Price
$0.45

Market Cap Chart

Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $20.59M, a decrease of -91.78%. That is a compound annual growth rate of -43.94%.

History

DateMarket Cap% Change
Apr 25, 202514.80M32.14%
Dec 31, 202411.20M-73.83%
Dec 29, 202342.80M-67.05%
Dec 30, 2022129.90M25.14%
Dec 31, 2021103.80M-58.58%
Dec 31, 2020250.60M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings